The influencing factors on the prognosis of patients with AML after chemotherapy by idarubicin combined with cytarabine
LUO Quanfang
WANG Wei
Machine-generated Keywords：
Publication Date：2022-03-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 868-871 )